Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
Saved in:
| Main Authors: | Antonio Bertoletti, Anthony T Tan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2024-10-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2024-0469.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
by: Kun-yan Hao, et al.
Published: (2025-01-01) -
Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes
by: Murali Ganesan, et al.
Published: (2025-01-01) -
Immunomodulatory effect of hepatitis B virus (HBV) antigens and MRSA antigens on immune response
by: Entidhar A. Hadi, et al.
Published: (2024-01-01) -
Hepatitis B virus infections in pregnant women and children in the era of HBV elimination
by: Malgorzata Pawlowska
Published: (2024-12-01) -
Modelling and Simulation of The Spread of HBV Disease.
by: Niyirora, Ignatius
Published: (2023)